$BSX News
Last published 2w ago
- 2w agoPENBSXPenumbra, Inc. Reports Third Quarter 2026 Financial ResultsPR NewswireALAMEDA, Calif., Oct. 29, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE:PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026.
- 2w agoBSXBOSTON SCIENTIFIC CORP - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2w agoBSXHTFLBoston Scientific announces results for third quarter 2026PR NewswireMARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational1 and
- 2w agoBSXBoston Scientific to participate in Stifel's 2026 Healthcare ConferencePR NewswireMARLBOROUGH, Mass., Oct. 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026. Kenneth Stein, M.D., senior vice
- 2w agoDGXSYKBSXMCKLab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breachTechCrunch
- 1mo agoBSXBoston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating OfficerPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating...
- 1mo agoJAMFHCKRMETAHAS+4Leaks, data breaches, and ransom notes: The worst hacks of 2026 so farTechCrunch
- 2mo agoMCKBSXSYKABT+4Hackers claim millions of patient records stolen during data breach at healthcare giant McKessonTechCrunch
- 2mo agoBSXABTMDTSYK+1Medical device maker Boston Scientific says a cyberattack is causing a ‘global disruption’ to its operationsTechCrunch
- 3mo agoBSXBoston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 resultsPR NewswireBoston Scientific Corporation (NYSE: BSX) will participate in Wells Fargo's 21st Annual Healthcare Conference on Thursday, September 10, 2026. Mike...
- 3mo agoPENBSXPenumbra, Inc. Reports Second Quarter 2026 Financial ResultsPR NewswirePenumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026....
- 3mo agoBSXBoston Scientific announces results for second quarter 2026PR NewswireBoston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported...
- 5mo agoBSXBERNSTEIN 42ND ANNUAL STRATEGIC DECISIONS CONFERENCEBOSTON SCIENTIFIC CORPEarnings Call TranscriptsAll right, hi everybody, I'm Lee Hambright, U.S. Medtech Analyst at Bernstein. We're very pleased to kick off the Strategic Decision Conference again with Boston Scientific. We've got Mike Mahoney, Chairman and CEO, and
- 5mo agoBSXFRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpointsPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced positive results from the pivotal FRACTURE Investigational Device Exemption (IDE) trial...
- 5mo agoBSXBoston Scientific enters into $2 billion accelerated share repurchase agreementPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan...
- 5mo agoBSXBoston Scientific announces strategic investment in MiRus LLCPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced it has invested $1.5 billion in return for an approximately 34% equity stake in MiRus LLC,...
- 6mo ago.SPX.IXICABTDHR+6Jim Cramer says today’s market is punishing stocks harder than 1999CNBCCNBC’s Jim Cramer said today’s market may resemble 1999 in some ways, but investors are punishing stocks even more aggressively.
- 6mo agoPENBSXPenumbra, Inc. Reports First Quarter 2026 Financial ResultsPR NewswirePenumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026....
- 6mo agoBSXBoston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 resultsPR NewswireBoston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on Wednesday, May 27, 2026. Mike ...
- 6mo agoBSXThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 4, 2026 in Boston Scientific Corporation Lawsuit - BSXGlobeNewswireNEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE:BSX). Shareholders who purchased shares of BSX during the class period
- 6mo agoBSXData at Heart Rhythm 2026 highlight key Boston Scientific therapiesPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's FARAPULSE™ Pulsed Field Ablation (PFA) Platform and...
- 6mo agoBSXBoston Scientific Q1 2026 Earnings CallBOSTON SCIENTIFIC CORPEarnings Call TranscriptsGood morning and welcome to the Boston Scientific first quarter 2026 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key
- 6mo agoBSXBoston Scientific announces results for first quarter 2026PR NewswireBoston Scientific Corporation (NYSE: BSX) generated net sales of $5.203 billion during the first quarter of 2026, growing 11.6 percent on a reported...
- 7mo agoBSXBoston Scientific announces conference call discussing first quarter 2026 resultsPR NewswireBoston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ...
- 7mo agoBSXBoston Scientific receives FDA clearance for the Asurys™ Fluid Management SystemPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Asurys™ Fluid Management...
- 7mo agoBSXACC CONFERENCEBOSTON SCIENTIFIC CORPEarnings Call TranscriptsGood evening, and welcome to the Boston Scientific American College of Cardiology conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressi
- 7mo agoBSXCHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpointsPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary safety and...
- 7mo agoBSXHI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolismPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced positive data from the HI-PEITHO global randomized clinical trial evaluating the use of the ...
- 8mo agoBSXCORTNKTRUNCYImportant Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- Boston Scientific Corporation (NYSE:BSX): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation
- 8mo agoBSXBoston Scientific to host investor event at the 75th Annual Scientific Session of the American College of CardiologyPR NewswireBoston Scientific Corporation (NYSE: BSX) will host an investor event and live webcast on Saturday, March 28, 2026, at 6:30 p.m. ET / 5:30 p.m. CT to ...
- 8mo agoBSXBoston Scientific elects Cathy Smith and Christophe Weber to Board of DirectorsPR NewswireBoston Scientific Corporation (NYSE: BSX) announced today the election of Cathy Smith and Christophe Weber to its Board of Directors, effective...
- 9mo agoBSXBoston Scientific to participate in TD Cowen's 46th Annual Health Care ConferencePR NewswireBoston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney,...
- 9mo agoBSXBoston Scientific Q4 2025 Earnings CallBOSTON SCIENTIFIC CORPEarnings Call TranscriptsGood morning and welcome to the Boston Scientific fourth quarter 2025 earnings call. All participants will be in listen only mode. Should you need assistance please signal a conference specialist by pressing star then ze
- 9mo agoBSXPENBoston Scientific announces results for fourth quarter and full year 2025PR NewswireBoston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported ...
- 9mo agoBSXBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)GlobeNewswireBALA CYNWYD, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
- 9mo agoBSXBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)GlobeNewswireBALA CYNWYD, Pa., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
- 10mo agoBSXBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)GlobeNewswireBALA CYNWYD, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
- 10mo agoBSXInvestor UpdateBOSTON SCIENTIFIC CORPEarnings Call TranscriptsGood morning and welcome to the Boston Scientific Investor Update. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your teleph
- 10mo agoBSXPENBoston Scientific announces agreement to acquire Penumbra, Inc.PR NewswireBoston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a definitive agreement...
- 10mo agoBSXBoston Scientific Announces Agreement to Acquire Valencia Technologies CorporationPR NewswireBoston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a...
- 10mo agoBSXBoston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 resultsPR NewswireBoston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in...
- 10mo agoBSXBOSTON SCIENTIFIC SCIMED, INC. - Appeal, ReversedUS Patent Trial and Appeal Board
- 11mo agoBSXCathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5PR NewswireCathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal...
- 1y agoBSXBoston Scientific announces upcoming investor conference schedulePR NewswireBoston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On November 18, 2025, Kenneth Stein, M.D., senior...
- 1y agoBSXBOSTON SCIENTIFIC SCIMED, INC. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoBSXBoston Scientific announces results for third quarter 2025PR NewswireBoston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported...
- 1y agoBSXBoston Scientific Announces Agreement to Acquire Nalu Medical, Inc.PR NewswireBoston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held...
- 1y agoBSXBOSTON SCIENTIFIC SCIMED, INC. - Appeal, ReversedUS Patent Trial and Appeal Board
- 1y agoBSXELUTElutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 MillionGlobeNewswire- Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market - GAITHERSBURG, Md., Oct. 01, 2025
- 1y agoBSXBOSTON SCIENTIFIC SCIMED, INC. - Appeal, ReversedUS Patent Trial and Appeal Board